BridgeMD
New treatment option for Breast Cancer, Stage 0
Official title Virtual Rehabilitation for Cancer Survivors
ClinicalTrials.gov ID: NCT05898789
What this study is testing
- What it's testing
- Pragmatic hybrid type 1 effectiveness-implementation (E-I) trial of a virtual cancer rehabilitation program: The study team will conduct a multi-center hybrid type I effectiveness-implementation study to examine the clinical effectiveness and implementation potential of an 8-week multidimensional virtual cancer rehabilitation intervention (CaRE@Home) for cancer survivors with identified cancer-related impairments on level of overall disability (primary outcome) and patient reported physical and social functioning, anxiety, work status, quality of life, and physiologic changes (secondary outcomes). The study team will conduct a multi-centre pragmatic randomized controlled trial (RCT) (Vancouver, Toronto, Saint John and St.
- Time commitment: about 6 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1) Age 18 years or older
- 2) Diagnosed with breast (stage 0-III), colorectal (stage I-III), head and neck (stage I-III), or lymphoma/lymphoproliferative disorder (excluded...
- 3) Completed a primary treatment (i.e. surgery and/or radiation and/or systemic therapy of any kind) within the last 24 months
- 4) If patients received systemic therapy of a fixed duration with adjuvant/curative intent, the main part should be completed, but patients are...
- 5) Communicate sufficiently in English to complete intervention and questionnaires
You likely can't join if
- 1) Impaired functional status that would preclude rehabilitation (PRFS \>3)
- 2) Indication of major depressive disorder (\> or = to 20 on PHQ-9)
- 3) Diagnosis of neurological disease or condition significantly limiting cognitive functioning, such as language or memory (e.g., Alzheimer's disease...
- 4) Currently enrolled in another personalized and supervised exercise or rehabilitation program
- 5) Conditions or current injuries which are not appropriate for distance based exercise (based on intake screening questions and as determined by...
See the full eligibility criteria
- 1) Age 18 years or older
- 2) Diagnosed with breast (stage 0-III), colorectal (stage I-III), head and neck (stage I-III), or lymphoma/lymphoproliferative disorder (excluded: recurrent, refractory, progressive, received or planning to receive...
- 3) Completed a primary treatment (i.e. surgery and/or radiation and/or systemic therapy of any kind) within the last 24 months
- 4) If patients received systemic therapy of a fixed duration with adjuvant/curative intent, the main part should be completed, but patients are eligible if on primary, maintenance, or other adjuvant systemic therapy...
- 5) Communicate sufficiently in English to complete intervention and questionnaires
- 6) Willing to be assigned by chance and participate in the intervention and attend in-person or virtual assessments
- 7) Internet access
- 8) An indication for cancer rehabilitation (WHO-DAS score \>5).
- 1) Impaired functional status that would preclude rehabilitation (PRFS \>3)
- 2) Indication of major depressive disorder (\> or = to 20 on PHQ-9)
- 3) Diagnosis of neurological disease or condition significantly limiting cognitive functioning, such as language or memory (e.g., Alzheimer's disease or other dementia, severe traumatic brain injury);
- 4) Currently enrolled in another personalized and supervised exercise or rehabilitation program
- 5) Conditions or current injuries which are not appropriate for distance based exercise (based on intake screening questions and as determined by physician\ . \ In cases where patient's indicate an existing higher risk...
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.